1. Home
  2. ICUCW vs PRME Comparison

ICUCW vs PRME Comparison

Compare ICUCW & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICUCW
    SELLHOLDBUYas of 2024 years ago
  • PRME
    SELLHOLDBUYas of 8 days ago
  • Stock Information
  • Founded
  • ICUCW N/A
  • PRME 2019
  • Country
  • ICUCW United States
  • PRME United States
  • Employees
  • ICUCW 12
  • PRME N/A
  • Industry
  • ICUCW Biotechnology: Pharmaceutical Preparations
  • PRME Medicinal Chemicals and Botanical Products
  • Sector
  • ICUCW Health Care
  • PRME Health Care
  • Exchange
  • ICUCW Nasdaq
  • PRME Nasdaq
  • Market Cap
  • ICUCW N/A
  • PRME N/A
  • IPO Year
  • ICUCW 2021
  • PRME 2022
  • Fundamental
  • Price
  • ICUCW $0.03
  • PRME $1.99
  • Analyst Decision
  • ICUCW
  • PRME Strong Buy
  • Analyst Count
  • ICUCW 0
  • PRME 9
  • Target Price
  • ICUCW N/A
  • PRME $13.25
  • AVG Volume (30 Days)
  • ICUCW N/A
  • PRME 1.6M
  • Earning Date
  • ICUCW N/A
  • PRME 05-09-2025
  • Dividend Yield
  • ICUCW N/A
  • PRME N/A
  • EPS Growth
  • ICUCW N/A
  • PRME N/A
  • EPS
  • ICUCW N/A
  • PRME N/A
  • Revenue
  • ICUCW N/A
  • PRME $2,983,000.00
  • Revenue This Year
  • ICUCW N/A
  • PRME $56.92
  • Revenue Next Year
  • ICUCW N/A
  • PRME $150.59
  • P/E Ratio
  • ICUCW N/A
  • PRME N/A
  • Revenue Growth
  • ICUCW N/A
  • PRME N/A
  • 52 Week Low
  • ICUCW N/A
  • PRME $1.37
  • 52 Week High
  • ICUCW N/A
  • PRME $8.27
  • Technical
  • Relative Strength Index (RSI)
  • ICUCW N/A
  • PRME 42.84
  • Support Level
  • ICUCW N/A
  • PRME $1.82
  • Resistance Level
  • ICUCW N/A
  • PRME $2.09
  • Average True Range (ATR)
  • ICUCW 0.00
  • PRME 0.18
  • MACD
  • ICUCW 0.00
  • PRME 0.03
  • Stochastic Oscillator
  • ICUCW 0.00
  • PRME 52.39

Stock Price Comparison Chart: ICUCW vs PRME

ICUCW
PRME
2023AprilJulyOctober2024AprilJulyOctober2025April0246810121416182022ICUCW VS PRME

About ICUCW SeaStar Medical Holding Corporation Warrant

SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use